Scott Wadler
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 79
- Colorectal Cancer Treatments and Studies 41
- Cancer Treatment and Pharmacology 15
-
- Ovarian cancer diagnosis and treatment 17
- Co-authors
- Edward L. Schwartz (26 shared papers)David Samuel Alberts (2 shared papers)Maurie M. Markman (2 shared papers)Della Makower (9 shared papers)Linda F. Carson (1 shared paper)Joshua Z. Sickel (1 shared paper)Brian N. Bundy (1 shared paper)Jeffrey M. Fowler (1 shared paper)
- Journals
- Journal of Clinical Oncology (27 papers)Cancer (13 papers)Gynecologic Oncology (11 papers)Investigational New Drugs (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Scott Wadler
177 papers receiving 8.2k citations
Scott Wadler's Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 4.0k
- Reproductive Medicine 926
- Otorhinolaryngology 282
- Hepatology 486
- Obstetrics and Gynecology 383
Countries citing papers authored by Scott Wadler
This map shows the geographic impact of Scott Wadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Wadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Wadler more than expected).
Fields of papers citing papers by Scott Wadler
This network shows the impact of papers produced by Scott Wadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Wadler. The network helps show where Scott Wadler may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Wadler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group Hit paper breakdown → | 2001 | 891 |
| 2 | 1997 | 531 | |
| 3 | 2004 | 477 | |
| 4 | 2001 | 369 | |
| 5 | 2007 | 364 | |
| 6 | Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. | 1990 | 308 |
| 7 | 1989 | 284 | |
| 8 | High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. | 1998 | 211 |
| 9 | 2001 | 203 | |
| 10 | 2000 | 159 | |
| 11 | 1991 | 132 | |
| 12 | A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. | 2001 | 132 |
| 13 | 1998 | 129 | |
| 14 | 2007 | 126 | |
| 15 | Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. | 2003 | 125 |
| 16 | 2004 | 123 | |
| 17 | Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. | 1990 | 118 |
| 18 | 2003 | 116 | |
| 19 | 1992 | 114 | |
| 20 | Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma. | 1990 | 111 |
About Scott Wadler
Scott Wadler is a scholar working on Oncology, Reproductive Medicine, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 179 papers that have together received 8.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (41 papers), Genetic factors in colorectal cancer (18 papers), Ovarian cancer diagnosis and treatment (17 papers), Cancer Treatment and Pharmacology (15 papers), Cancer therapeutics and mechanisms (15 papers), Lung Cancer Treatments and Mutations (14 papers), Gastric Cancer Management and Outcomes (11 papers) and Endometrial and Cervical Cancer Treatments (9 papers). The work is most often cited by research in Oncology (4.0k citations), Reproductive Medicine (926 citations), Otorhinolaryngology (282 citations), Hepatology (486 citations) and Obstetrics and Gynecology (383 citations). Scott Wadler has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Edward L. Schwartz, David Samuel Alberts, Maurie M. Markman, Della Makower, Linda F. Carson, Joshua Z. Sickel, Brian N. Bundy, Jeffrey M. Fowler, Al B. Benson and Jonathan Jay Beitler. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Gynecologic Oncology, Investigational New Drugs and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.